← News
Aug 28, 2026 Psychedelics
New on Altitude: Who's Actually Making Money on Depression, Anxiety, and PTSD
The drugs most Americans take for depression and anxiety are decades-old generics that make pharma almost nothing. We mapped the five newer, still-patented drugs actually driving revenue in this space — and how fast two of them are about to lose that protection. Read the brief here.
Read at Altitude